Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.17 USD | 0.00% | -2.05% | -9.57% |
May. 13 | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
May. 10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.65% | 17.92B | |
-5.31% | 182B | |
+3.47% | 114B | |
-3.65% | 68.38B | |
+6.12% | 52.46B | |
+7.81% | 44.25B | |
+7.52% | 43.55B | |
+24.87% | 32.69B | |
+17.85% | 26.73B | |
+0.27% | 25.79B |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- Insider Sell: Baxter International